Elekta will integrate cancer workflow and patient management tools into the Proteus TK2, a proton therapy center from Belgium-based Ion Beam Applications (IBA).

The intergovernmental Nuclear Energy Agency (NEA) has called for fundamental changes in government policy and cooperation with industry to reform what the agency identified as an unsustainable economic structure for the supply of isotopes for nuclear medicine.

The National Patient Safety Foundation has awarded $200,000 in grants to researchers for projects studying rapid response team care and patient handoffs.

Radiologists preferences and use of 2D, 3D or 2D/3D CT colonography (CTC) does not affect their performance in the detection of polyps 6 mm or larger, according to a large multi-institution study published in the May issue of Radiology.

Molecular Insight Pharmaceuticals (MIP) has announced that at a hearing held on May 5, the U.S. Bankruptcy Court for the District of Massachusetts confirmed the company's Amended Plan of Reorganization, and MIP is scheduled to emerge from Chapter 11 as a fully restructured company by late May.

Speare Memorial Hospital, of Plymouth, N.H., has sent notification letters to nearly 6,000 patients that their protected health information (PHI) may have been breached following the theft of a laptop, according to a notice on the hospitals website.

IBA Group, which develops cancer diagnosis and therapy technologies, and Royal Philips Electronics have entered into an agreement to create patient-centric proton therapy centers.

Bioptigen has created the spectral domain optical coherence tomography (SDOCT) imaging system for preclinical applications.